Oxford BioMedica (OXB LN) received an approach from EQT and deadline for the offer is 11th February

Oxford BioMedica's receipt of an approach from EQT suggests potential interest in consolidation within the biotech sector, which could enhance shareholder value if the deal is strategically sound.

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

Newsquawk Daily US Earnings Estimates - 15th January 2026: BLK, GS, MS, TSM

Trump admin reportedly nearing trade and investment deal with Taiwan

Oxford BioMedica (OXB LN) received an approach from EQT and deadline for the offer is 11th February

Deal team inside Paramount Skydance (PSKY) are meeting now on how to respond to Netflix's (NFLX) latest move to go all-cash in its offer for Warner Bros Discovery (WBD), discussing possibility of upping the bid, according to FBN's Gasparino

Russian official says US attack on Iran would be "gravest mistake"

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

As the offer deadline of February 11 approaches, market participants will be keenly watching for any developments regarding terms and potential regulatory hurdles, impacting both OXB's share price and broader sentiment in related sectors.

Related headlines

The whole workspace, free to try.

Try it free